Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Neuro drug > Drugs indication > Flashcards

Drugs indication Flashcards

1
Q

Midazolam

A

SA

  • Anxiety
  • Induction of general anesthesia
  • procedural sedation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Triazolam

A

SA

  • insomnia
  • hypnotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Alprazolam

A

IA

  • Anxiety
  • Panic disorder
  • Sedative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clonazepam

A

IA

  • Panic disorder
  • seizure
  • Anti-convulsant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lorazepam

A

IA

  • Anxiety
  • insomnia
  • status epilepticus
  • sedative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

oxazepam

A

IA

  • Alcohol withdrawal syndrome
  • anxiety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Temazepam

A

IA

  • Insomnia
  • Hypnotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Chlordiazepoxide

A

LA

  • Alcohol withdrawal syndrome
  • anxiety
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Flurazepam

A

LA

  • insomnia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diazepam

A

LA

  • Alcohol withdrawal syndrome
  • anxiety
  • sedation
  • status epilepticus
  • seizure
  • hypnotics
  • pre-anaesthetics
  • anti-convulsant
  • refractory seizure
  • adjunct skeletal muscle spasm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Anxiety

A

Midazolam (SA)
Alprazolam (IA)
Lorazepam (IA)
Diazepam (LA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Panic disorder

A

Alprazolam (IA)

Clonazepam (IA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

insomnia

A

Triazolam (SA)
lorazepam (IA)
temazepam (IA)
Flurazepam (LA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alcohol withdrawal syndrome

A

Oxazepam (IA)
Chlordiazepoxide (LA)
Diazepam (LA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Status epilepticus

A

Lorazapam (IA)

Diasepam (LA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Chlorpromazine

A

Typical Antipsychotics
(antiD2)

M1: Dry mouth, constipation, blurred vision
H1: sedation, weight gain
A1: Postural hypotension,dizziness.
D2: EPS (Acute Dystonias, Tardive Dyskinesia, Akath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Haloperidol

A

Typical Antipsychotics
(antiD2)

A1: Postural hypotension,dizziness.
D2: EPS (Acute Dystonias, Tardive Dyskinesia, Akathisia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clozapine

A

Atypical antipsychotics

M1: Dry mouth, constipation, blurred vision
H1: sedation, weight gain
A1: Postural hypotension,dizziness.
- agranulocytosis (Agranulocytosis is the lack of granulocyte type white blood cells)
(● Regular blood counts are required to monitor patients.)
- Diabetes
- wt gain

Led to development of compounds related to clozapine but without this adverse effect e.g. olanzapine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

olanzapine

A

Atypical antipsychotics

M1: Dry mouth, constipation, blurred vision 
H1: sedation, weight gain
A1: Postural hypotension,dizziness. 
- Diabetes
- wt gain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

risperidone

A

Atypical antipsychotics

Postural hypotension, reflex tachycardia
● Due to α1-adrenoceptor antagonism.
- Diabetes
- wt gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Amisulpride

A

Amisulpride is a selective D2/D3 antagonist (but recently also reported to have 5-HT7 antagonism). For an atypical antipsychotic, it has an atypical pattern of receptor affinities.

 Few side-effects due to selectivity for D2 / D3 receptors.
 Absence of α-adrenoceptor block, antihistaminergic, and anticholinergic side-effects.

Adverse effects on mammary glands and tissues:
● Increased prolactin secretion due to block of dopamine receptors in the anterior pituitary gland.
● Breast swelling, pain, and lactation.
● Presents as gynaecomastia in males.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Aripiprazole

A

partial agonists

H1: sedation, weight gain
A1: Postural hypotension,dizziness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Typical antipsychotics

A

chlropromazine
Fluphenazine
Haloperidol
Trifluoperazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Atypical antipsychotics

A 
Clozapine
olanzapine
risperidone
Amisulpride
Aripiprazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Benzodiazepine antagonist

A

Flumazenil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

LA Barbiturates and their indication

A

Anticonvulsant
- Phenobarbital

1-2days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

SA Barbiturates and their indication

A

Sedative and hypnotic

  • pentobarbital
  • amobarbital

3-8hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

US Barbiturates and their indication

A

IV induction of anesthesia
- Thiopental

20min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

BZD ADR

A

– Drowsiness, confusion, amnesia.
– Impaired muscle co-ordination (impairs manual skills).

– Can cause severe respiratory depression, especially used concurrently with alcohol.

Treatment is by flumazenil, a benzodiazepine antagonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Barbiturates ADR

A

– Can cause severe respiratory depression, especially used concurrently with alcohol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Levodopa

A

1st line parkinson

  • First available in 1960s
  • Dopamine precursor, “2-in-1” preparation with carbidopa, a DOPA-decarboxylase inhibitor to prevent side effects due to excess DA in PNS (Eg, Levodopa + carbidopa: Sinemet)

-L-dopa –> dopamine ( enzyme = DOPA decarboxylase)
therefore prevent conversation of dopa to dopamine at PNS.
Carbidopa cannot pass BBB. so only stay at PNS. and also increase half life of dopa

Strategy to increase dopamine synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Side effect of levodopa

A

– Short term: nausea, vomiting, postural hypotension
– Long term: motor fluctuations and dyskinesia (10%/yr)

– Although levodopa is the most efficacious drug for the symptomatic management of both early and late Parkinson’s disease, the dose of levodopa should be kept to the minimum necessary to achieve good motor function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Entacapone(Comtan®) or Tolcapone (Tasmar®)

A

Strategy: inhibit dopamine breakdown with COMT inhibitors

  • blocks COMT conversion of dopamine into an inactive form
  • more levodopa is available to enter the brain (reduces required dose)
  • only effective if used with levodopa
  • increases duration of each dose of levodopa, beneficial in treating “wearing off” responses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Entacapone(Comtan®) or Tolcapone (Tasmar®)

A

Entacapone(Comtan®) or Tolcapone (Tasmar®)

  • Increase abnormal movements (dyskinesias)
  • Liver dysfunction (Tolcapone)
  • Nausea, diarrhea
  • Urinary discoloration
  • Visual hallucinations
  • Daytime drowsiness, sleep disturbances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Selegiline or rasagiline(Azilect®)

A

Strategy: inhibit dopamine breakdown with MAO-B inhibitors

  • Mild antiparkinson activity
  • Inhibits enzyme monoamine oxidase B, interferes with breakdown of dopamine
  • Laboratory studies suggest that it may delay the nigral brain cell degeneration

Selegiline is efficacious as a symptomatic monotherapy and may be used in early stages of Parkinson’s disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Selegiline or rasagiline(Azilect®) ADR

A
  • Heartburn, loss of appetite
  • Anxiety, palpitation, insomnia
  • Nightmares, visual hallucination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Bromocriptine

A 
Dopamine agonists 
• Used since 1970s, adjunct or monotherapy 
• Available as 
– Bromocriptine(Parlodel®) 
– Pergolide(Celance®, Permax®) 
– Ropinirole(Requip®)
  • Act directly on dopamine receptors in the brain to reduce the symptoms of PD
  • Antiparkinsonianeffects not superior to levodopa (levodopa still the gold standard)
  • Prevent or delay onset of motor complications

In younger Parkinson’s disease patients, therapy should commence first with dopamine agonists rather than levodopa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Pergolide

A 
Dopamine agonists 
• Used since 1970s, adjunct or monotherapy 
• Available as 
– Bromocriptine(Parlodel®) 
– Pergolide(Celance®, Permax®) 
– Ropinirole(Requip®)
  • Act directly on dopamine receptors in the brain to reduce the symptoms of PD
  • Antiparkinsonianeffects not superior to levodopa (levodopa still the gold standard)
  • Prevent or delay onset of motor complications

In younger Parkinson’s disease patients, therapy should commence first with dopamine agonists rather than levodopa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Ropinirole

A 
Dopamine agonists 
• Used since 1970s, adjunct or monotherapy 
• Available as 
– Bromocriptine(Parlodel®) 
– Pergolide(Celance®, Permax®) 
– Ropinirole(Requip®)
  • Act directly on dopamine receptors in the brain to reduce the symptoms of PD
  • Antiparkinsonianeffects not superior to levodopa (levodopa still the gold standard)
  • Prevent or delay onset of motor complications

In younger Parkinson’s disease patients, therapy should commence first with dopamine agonists rather than levodopa.

40
Q

dopamine agonists side effect

A

– Bromocriptine(Parlodel®)
– Pergolide(Celance®, Permax®)
– Ropinirole(Requip®)

  • ‘Ergot’ derivative –fibrosis
  • Pedal edema
  • Somnolence (ropinirole)
  • Restrictive valvular heart disease (pergolide)
41
Q

Dopaminergic drug

A

 Levodopa (+/-carbidopa)
 Entacapone/ Tolcapone
 Selegiline/ rasagiline
 Bromocriptine/ pergolide/ ropinirole

42
Q

non dopaminergic drug

A

amantadine

trihexyphenidyl

43
Q

Amantadine

A

• Antiviral agent, accidentally discovered to have mild antiparkinsonianeffect (tremor, rigidity, bradykinesia, dyskinesia).

• Given as monotherapy or adjunct to levodopa.
• Mechanism of action:
– Enhance release of stored dopamine
– Inhibit presynaptic uptake of catecholamine
– Dopamine receptor agonist
– NMDA receptor antagonist (anti-glutamate)
• Antidyskinetic

Amantadine may be considered as therapy to reduce dyskinesia in patients with Parkinson’s disease who have motor fluctuations

44
Q

Amantadine ADR

A

Side effects limit its use in advanced disease:
–Cognitive impairment (inability to concentrate), hallucination, insomnia, nightmares, livedo reticularis (Venule swelling due to thromboses –> mottled reticulated discoloration of limbs).

45
Q

Trihexyphenidyl(Artane®)

A

anticholinergics

Advantages:
– May be effective in controlling tremor
– Peripherally acting agents may be useful in treating sialorrhoea

Anticholinergic agents may be used as symptomatic monotherapy or as an adjunct to levodopa to treat tremors and stiffness in Parkinson’s disease.

46
Q

Trihexyphenidyl(Artane®) ADR

A

• Side effects (especially in elderly): – Dry mouth, sedation, constipation, urinary retention, delirium, confusion, hallucinations

47
Q

Medication for epilepsy

A

Antiepileptics (I)
 Phenytoin
 carbamazepine
 Valproate

Antiepileptics (II) 
 Pregabalin
 Vigabatrin 
 Lamotrigine
 Others eg, BZDs

BZD is additive therefore not a good choice coz epilepsy is lifelong

48
Q

Phenytoin

A

Blockade of voltage-depedent Na+ channels.
• Suitable for all types of seizures except absence seizures.
• A relative narrow therapeutic range (plasma concentration 40-100 μM), saturation kinetics and consequent non-linear relationship between dose and plasma concentration necessitates titration and monitoring.

49
Q

ADR of Phenytoin

A
  • hypothyroidism
  • gum hypertrophy
  • confusion and difficulty balancing –> involve cerebellar and vestibular system -> ataxia, vertigo
  • craniofacial abnormalities with prenatal exposure
  • folate and B12 deficiency
  • immunosuppresant
  • hirsutism
overdose 
= 
convusion
cerebellar 
vestibular
B12 / folate deficiency

hypersensitivity
- morbiliform
lupus like
megaloblastic anaemia

teratogenic

50
Q

Carbamazepine

A

Blockade of voltage-depedent Na+ channels (like phenytoin).
• Suitable for all types of seizures except absence seizures.
• Hepatic enzyme (CYP450) inducer, T½ shortens with repeated doses —–> accelerates elimination of other drugs.

51
Q

Carbamazepine ADR

A

Dose dependent

  • GI Upset
  • Diplopia
  • nystamus
  • drowsiness
  • folate vit D def
  • antidiuretic effect

Overdose

  • Ataxia
  • Confusion
  • Behavioral-disturbance

hypersensitivity

  • Bone marrow
  • Rashes
  • SLE
  • SJS
  • Lymphadenopathy
  • Hepatitis

Teratogenic

  • In animals
  • In human??
52
Q

Valproate

A
  • Blockade of voltage-dependent Na+ and Ca2+ channels.
  • Also inhibits GABA transaminase —-> increased GABA
  • Suitable for all types of seizures, including absence seizures.
  • Strongly bound to plasma proteins, displaces other antiepileptics.
53
Q

Valproate ADR

A

Dose dependent

  • GI upset
  • Sedation
  • wt gain
  • hair loss

Hypersensitivity

  • hepatotoxicity
  • Thrombocytopenia

Teratogenic

  • Spina bifida
  • CVS
  • Orofacial
  • Digital
54
Q

pregabalin

A

second gen AED
potentiate the release of GABA
–GABA analogue, increases synaptic GABA –> GABA receptor mediated Cl- currents resulting in hyperpolarization.

–Also acts on voltage-gated Ca2+channels.
–Besides GAD (ANXIETY), also used as add-on therapy for partial seizures (SEIZURE)

55
Q

pregabain ADR

A

–Adverse effects, mainly SEDATION, may be associated with emergence of worsening of SUICIDAL thoughts.

therefore not good for depression

56
Q

Buspirone

A

–A serotonin 5-HT1A receptor partial agonist. Also binds dopamine receptors.

–Indicated for GAD but anxiolytic effects takes 1-2 weeks.

–Lacks anticonvulsant and muscle relaxant properties.

57
Q

Propanolol

A

A beta-adrenergic receptor antagonist (“betablocker”).

–Used for treating performance anxiety and social phobias.

–Reduces physical symptoms associated with adrenergic activation.

–Contraindicated in patients with asthma and heart conditions.

58
Q

Hydroxyzine

A

–A first generation antihistamine with activities on serotonergic and α-adrenergic receptors.

–Anxiolytic effects attributed to antagonism of serotonin 5-HT2 receptors.
–Has low addictive potential compared to BZDs and barbiturates.
–Because of antihistamine activities, also helps with itching.

59
Q

vigabatrin

A

second gen AED

–Inhibits GABA transaminase —> increased synaptic GABA (» valproate).
–Useful in all types of seizures, including those refractory to other AEDs.

60
Q

vigabatrin ADR

A

–Side effects: Sedation, behavioural and mood changes (occasionally psychosis), visual field defects.

61
Q

Lamotrigine

A

second gen AED
- –Blockade of voltage-depedent Na+ channels.
–Also inhibits glutamate release.
–For all types of seizures.

62
Q

Lamotrigine

A

–Side effects: Dizziness, sedation, rashes.

63
Q

BZD and barbiturates

A

epilepsy also

64
Q

Phenelzine

A

An irreversible MAO inhibitor.

depression

65
Q

MAO inhibitor. ADR

A

 Postural hyoptension

• Probably due to sympathetic block produced by accumulation of dopamine in the cervical (neck) ganglia, where is acts as an inhibitory transmitter

 Restlessness and insomnia due to central nervous system (CNS) stimulation

66
Q

MAOI DDI FDI

A

1) pethidine
2) cheese
3) concentrated yeast product (eg marmite)
4) tyramine (amines in food)

 Should not be combined with or other drugs enhancing serotoninergic function (e.g. pethidine)
cause–> • Hyperexcitability, increased muscular tone, myoclonus (jerking, involuntary movements), loss of consciousness

The cheese reaction

  • Major limitation on the use of MAOIs.
  • Acute hypertension, giving severe throbbing headache, and occasionally intracranial haemorrhage.

Less likely to occur with MAO-A selective, reversible MAOIs (e.g. moclobemide).

 Amines (e.g. tyramine) in foods (e.g. cheese) are usually broken down by MAO in the intestines and liver.  MAOIs can lead to accumulation of tyramine and a sympathomimetic effect.
 Dangerous food interactions with MAO blockers (e.g. acute hypertension).

Tyramine is taken up into adrenergic terminals and competes with NA for the vesicular compartment.

67
Q

Imipramine, Amitriptyline, nortriptyline

A

Non-selective for SERT/NET:

Depression

68
Q

Desipramine

A

Selective for NET:

Desipramine

69
Q

TCA ADR

A

 Sedation
•Due to H1 histamine receptor antagonism
•Tolerance to sedation can develop in 1-2 weeks

 Postural hypotension
•Due to α-adrenoceptor sympathetic block

 Dry mouth, blurred vision, constipation
•Due to muscarinic receptor antagonism

 Risk of drug induced cardiac dysrhythmias
•Perhaps due to block of HERG potassium channel

70
Q

SSRI adv

A

Low affinity for α adrenoceptors ——–>
Lack of cardiovascular effects, safer in overdose

Lack of effect at histamine receptors ————–>
Reduced sedation

Low affinity for muscarinic cholinergic receptors ——–>
Minimal anticholinergic side effects (e.g. dry mouth and constipation)

Overall SSRIs are safer in overdose and less side effects lead to better compliance.

 Adverse effects of TCAs lead to prescription of subtherapeutic doses.
 Improved adverse effect profile of SSRIs leads to better compliance and so prescription of more adequate doses.

basically good

1) efficacy
2) safety
3) tolerability

1st line therapy. but not perfect…..
• Only 2/3 get remission
• Adverse effects especially at start
• Discontinuation can be a problem in some

71
Q

Fluoxetine
Citalopram
ADR

A

 Nausea
 Insomnia
 Sexual dysfunction

N AND I
- May be discontinuation/rebound symptoms of withdrawal when plasma levels of drug

 SSRI-induced sexual dysfunction
 Men = delayed ejaculation
 Women = delayed or blocked orgasm (anorgasmia)
 Reported by up to 50% of patients on SSRIs
 But rarely [<10%] leads to discontinuation
 Due to increased stimulation of 5HT2 receptors

Cyproheptadine or other 5HT2 blockers
can be given to prevent SSRI-induced sexual dysfunction

Citalopram still has some histamine receptor antagonism leading to sedation.

72
Q

Reboxetine

A

Noradrenaline Reuptake Inhibitors (NARIs)

Depression

73
Q

Fluoxetine

Citalopram

A

SSRI

depression

74
Q

Serotonin syndrome

A 
1) serotonin syndrome 
 Severe reaction can result from drug-drug interactions with other drugs increasing serotoninergic activity (e.g. MAOIs). 
 Effects include: 
 tremor 
 hyperthermia 
 cardiovascular collapse
75
Q

Reboxetine

A

Noradrenaline Reuptake Inhibitors (NARIs)

 New drug so adverse effects not well described.
 Dry mouth (11 %)
 Constipation (9 %)
 Insomnia (approx. 9 %)
- Probably due to increased noradrenergic activity in the central nervous system.
 Tachycardia (approx. 3%)
- Probably due to increased availability of NA at sympathetic “fright, flight or fight” synapses.

76
Q

Venlafaxine
desvenlafaxine
duloxetine

A

Serotonin and Noradrenaline reuptake Inhibitors (SNRIs)

Depression

77
Q

Serotonin and Noradrenaline reuptake Inhibitors (SNRIs)

adv

A

Different structure to TCAs and fewer adverse effects than TCAs.
 Claimed to work slightly faster than other antidepressants.
 Claimed to work better in treatment-resistant patients

78
Q

Venlafaxine
desvenlafaxine
duloxetine

ADR

A

 Serotoninergic adverse effects similar to SSRIs:
 Nausea
 Insomnia
 Sexual dysfunction
 “Serotonin syndrome” when combined with other serotoninergic drugs and MAOIs.
 Withdrawal effects may be more common and stronger than for SSRIs and TCAs.

79
Q

 Mirtazapine:

A

a norepinephrine and specific serotonin antidepressant (NaSSA). Antagonist of adrenergic α2 autoreceptors and 5-HT2C receptor, among others.

Depression

80
Q

 Bupropion:

A

a norepinephrine-dopamine reuptake inhibitor (NDRI).

Depression

81
Q

 Agomelatine:

A

agonist of melatonin MT1 and MT2 receptors, less TCA / SSRI-associated side-effects, also helps in sleep disorders.

depression

82
Q

 Ketamine:

A

a glutamate NMDA receptor antagonist used as an anesthetic, currently evaluated for rapid-onset antidepressant effect.

depression

83
Q

effect of opioid

A

Spinal Analgesia
Peripheral Analgesia

Pupil constriction
Supraspinal Analgesia
Cough suppression

Reduced gut motility
Constipation

Dysphoria
Respiratory depression
Euphoria 
Severe sedation 
Sedation
84
Q

opioid Analgesia:

A

 Analgesia: Codeine, morphine, pethidine

85
Q

Anaesthetic adjuvant opioid

A

Anaesthetic adjuvant: Fentanyl

86
Q

opioid Anti-diarrhoeal:

A

Anti-diarrhoeal: Diphenoxylate

87
Q

Cough suppressant / antitussive:

A

Cough suppressant / antitussive: Codeine

88
Q

Strong Opioid Agonists

and receptor binding efficacy addiction

A

Morphine:
 Strong m agonist (weaker d and kagonist).
 High maximum analgesic efficacy.
 High liability for addiction/abuse.

Methadone and Fentanyl:
 Strong m agonists (no significant d and kaffinity).
 High maximum analgesic efficacy.
 High liability for addiction/abuse

Methadone is long-acting (plasma half-life > 24 hrs).
Fentanyl is short-acting (anaesthetic adjuvant).

Pethidine (Meperidine):
 Strong m agonist (probably weaker d and kagonist).
 Shorter duration of action than morphine (especially in neonate therefore used in labour).
 N-demethylated in the liver to norpethidine (hallucinogenic and convulsant effects at high dose)
 Restlessness rather than sedation

 Antimuscarinic (i.e. parasympatholytic) therefore dry mouth, blurring of vision but no miosis and less spasm of smooth muscle.

89
Q

Moderate opioid agonists

A

Codeine / Dihydrocodeine:
 Weak m and d agonist (probably not a k agonist).
 Low maximum analgesic efficacy.
 Moderate liability for addiction/abuse.
 ~10 % converted to morphine / dihydromorphine.
 ~10 % of population show reduced analgesic effect due to lack of demethylating enzyme.

Tramadol:
 Weak m agonist.
 Weak inhibitor of 5-HT and noradrenaline re-uptake

Ondansetron blocks analgesic effect: Also a 5-HT3 agonist?

90
Q

opioid common adr

A

Nausea / vomiting
most probably due to actions on the chemoreceptor trigger zone in the area postrema of the medulla (usually reduces with repeated or chronic use).

Constipation
due to reduced gastrointestinal motility (esp. with chronic use).

Miosis (pinpoint pupils)
due to actions in the oculomotor nucleus.
Pinpoint pupil is a diagnostic feature of opioid overdose
But note that mydriasis can also follow if hypoxia occurs.

Urinary retention
due to increased bladder sphincter tone (esp. in patients with prostatic hypertrophy.)

Postural hypotension and bradycardia
due to actions in cardioregulatory nuclei in the medulla.

Drowsiness

Morphine can also trigger histamine release from mast cells
urticaria and itching
bronchoconstriction
hypotension due to vasodilatation

Morphine should be used with caution in asthmatics.

Immunosuppressant effect with long-term use, most likely through CNS effects on the immune system.

91
Q

opioid withdrawal syndrome

A 
anxiety, 
irritability, 
chills, 
hot flushes, 
joint pain, 
lacrimation (tears), 
rhinorrhea (runny nose),
nausea, 
vomiting, 
abdominal cramps, 
diarrohea.
92
Q

Opioid Antagonists

A

Naloxone / Naltrexone / Nalmefene:
 Strong m antagonism; also d and k antagonism.
 Naloxone is short-acting (usually intravenous)
 Naltrexone is long-acting (oral administration)
 Nalmefene is long-acting (intravenous)
 Used to counteract opioid overdose.

Use with extreme caution in patients with opiate dependency as they can precipitate potentially fatal withdrawal syndrome.

93
Q

Naloxone

A

 Naloxone is short-acting (usually intravenous)

opioid antagonist

94
Q

Naltrexone

A

 Naltrexone is long-acting (oral administration)
 Nalmefene is long-acting (intravenous)

opioid antagonist

95
Q

Nalmefene

A

 Nalmefene is long-acting (intravenous)

opioid antagonist

Neuro drug (21 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions